Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.900
+0.020 (1.06%)
At close: Jun 12, 2026, 4:00 PM EDT
1.900
0.00 (0.00%)
After-hours: Jun 12, 2026, 7:39 PM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $655.79 million as of June 12, 2026. Its market cap has increased by 154.08% in one year.
Market Cap
655.79M
Enterprise Value
475.14M
1-Year Change
154.08%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $655.79M, a decrease of -77.23%. That is a compound annual growth rate of -17.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 655.79M | 113.00% |
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 702.93M |
| Aura Biosciences | 684.96M |
| Relmada Therapeutics | 683.88M |
| Oculis Holding AG | 664.27M |
| Design Therapeutics | 657.67M |
| CytomX Therapeutics | 648.75M |
| Tenax Therapeutics | 631.76M |
| Aclaris Therapeutics | 610.33M |